about
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungPneumococcal Capsules and Their Types: Past, Present, and FutureGenetic requirement for pneumococcal ear infectionIn vivo capsular switch in Streptococcus pneumoniae--analysis by whole genome sequencing.Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties.Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion.Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression.Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children.PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation.Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity?Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposonRequirement for capsule in colonization by Streptococcus pneumoniae.Within-host competition drives selection for the capsule virulence determinant of Streptococcus pneumoniaeUpper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type.Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virusInhibition of T cells provides protection against early invasive pneumococcal diseaseGMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in ScotlandMathematical model of a three-stage innate immune response to a pneumococcal lung infectionMultiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease.Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice.Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils.Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue.Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunityImmune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.CcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon.Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.Vaccination against colonizing bacteria with multiple serotypes.Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.Oropharyngeal production of pneumococcal capsular antigen and the potential for contamination of expectorated sputum samples in pneumococcal pneumoniaThe pneumococcal problem.Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence studyPneumococcal resistance to antibiotics.
P2860
Q21131368-B48EA774-54A6-4F4B-AE69-50FA9BE24BD2Q27006887-198C34AD-8DDB-41FD-BF61-5D12D8CCED41Q28474281-E5DBB973-11A9-4F58-A0EC-951FC8A23AB0Q30423476-02CC39D3-4A4C-49E4-BA70-42CB18D15B47Q33239521-E50437B6-FDCB-40D1-B863-1FEBB355D9E6Q33255474-725CF215-15E3-4151-AD93-289595BCF696Q33497638-E18D690F-C5F2-44DF-86CB-99652F0E87F4Q33566530-11413B2C-4FD5-4FEA-98B8-9127002BD3A3Q33768825-0F611E07-AB3F-427C-888B-9114E5AE69DDQ33826507-1CF736AF-6660-496B-A577-4DC0F1943153Q33909187-9E678A2C-5790-4E27-9E84-45E77B326445Q33935327-9E269596-58B3-484D-974D-94CC0271488FQ33946696-72C64324-B652-4CD0-A403-FB6B43B731E7Q34007388-FA986416-3F0D-4F12-9C8E-990606AAE3BCQ34007742-81FC0EBC-5C40-410C-BEF3-C5C6EC874CA8Q34032902-BD05D657-551E-4D0C-91ED-F1DB31599EE0Q34123722-66B95C71-165F-4625-AF7A-EC625DB3D558Q34261558-A109B953-B0C2-422F-9758-6161D254E320Q34309777-9026F121-08C8-405A-92B4-FFAFD9C290ABQ34310321-A5809733-1873-4787-8E16-C30A43CA21B2Q34569142-F69D724C-9589-48A1-A496-D3376D0ECE8AQ34733562-6115E64D-8751-4C67-928F-CFA4825C07E2Q34760949-E1E3F5CB-6C0B-4608-B096-6F694C2CDFC9Q34762735-5BBC3310-F3DA-4934-8FEA-CD9330D6ADC2Q34768051-CBF52F48-44D4-4316-B979-A68796908013Q34975633-745BCC4B-C14F-40C6-B292-40A55B86D0C7Q35187119-9722E196-2274-4B3F-B90E-D46C727A3BE7Q35549220-86E1A0A8-EA67-4579-A893-FFF344D44AF4Q35586932-8E50AE80-8CA8-46BA-AF06-F0E9EB510EAFQ35782997-4E57E8CB-49C0-4913-8873-B930A15A312BQ35844906-59B5A472-AC8E-4AF6-807E-7AFC1E0272CDQ35874108-E50516A3-67C1-48B7-84E4-0362F7D97E67Q35949387-AFE5322F-9184-45D5-9016-DEABA4094771Q36013814-9AF769D3-D612-483F-B706-4ED2F20EE7B7Q36195678-348C2D1A-B877-43C1-8844-AAA626AB9FC7Q36313904-021661F9-7B6B-4F5D-A365-ECF9E389BEB5Q36506220-C2D6F3D2-9A1F-4FCA-8E29-99CB94D605E6Q36598884-91E1D5CB-BF1A-4B2B-B072-6D55AE7B31BBQ36599754-F4CF80CA-6778-44A8-BB30-84B88665EC44Q36636190-EE69933B-FBEF-4427-9F56-C20F13349F80
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Some aspects of the pneumococcal carrier state.
@en
Some aspects of the pneumococcal carrier state.
@nl
type
label
Some aspects of the pneumococcal carrier state.
@en
Some aspects of the pneumococcal carrier state.
@nl
prefLabel
Some aspects of the pneumococcal carrier state.
@en
Some aspects of the pneumococcal carrier state.
@nl
P1476
Some aspects of the pneumococcal carrier state.
@en
P2093
Austrian R
P356
10.1093/JAC/18.SUPPLEMENT_A.35
P407
P478
18 Suppl A
P577
1986-07-01T00:00:00Z